Erwin M. Wiegman

877 total citations
20 papers, 625 citations indexed

About

Erwin M. Wiegman is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, Erwin M. Wiegman has authored 20 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Radiation. Recurrent topics in Erwin M. Wiegman's work include Lung Cancer Diagnosis and Treatment (8 papers), Advanced Radiotherapy Techniques (6 papers) and Medical Imaging Techniques and Applications (5 papers). Erwin M. Wiegman is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Advanced Radiotherapy Techniques (6 papers) and Medical Imaging Techniques and Applications (5 papers). Erwin M. Wiegman collaborates with scholars based in Netherlands, Germany and South Africa. Erwin M. Wiegman's co-authors include Johannes A. Langendijk, Joachim Widder, Harry J.M. Groen, Jan Pruim, Jan F. Ubbels, Vikram Rao Bollineni, Theo J. Klinkenberg, Robert P. Coppes, Douwe Postmus and Michel Koole and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Thorax and European Journal of Cancer.

In The Last Decade

Erwin M. Wiegman

20 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erwin M. Wiegman Netherlands 12 413 296 169 147 108 20 625
Paul Meijnders Belgium 14 355 0.9× 197 0.7× 227 1.3× 195 1.3× 88 0.8× 35 791
Amanda Foster United States 15 542 1.3× 249 0.8× 201 1.2× 163 1.1× 29 0.3× 29 648
Harvey Quon Canada 17 629 1.5× 181 0.6× 431 2.6× 97 0.7× 45 0.4× 67 884
Cristian Udovicich Australia 11 934 2.3× 447 1.5× 103 0.6× 143 1.0× 122 1.1× 35 1.1k
Christine Verfaillie Netherlands 9 508 1.2× 322 1.1× 223 1.3× 346 2.4× 95 0.9× 10 873
Sharon Salenius United States 18 840 2.0× 177 0.6× 342 2.0× 244 1.7× 72 0.7× 48 1.0k
P. Pedicini Italy 13 229 0.6× 221 0.7× 183 1.1× 66 0.4× 42 0.4× 30 490
Michelle Leech Ireland 14 195 0.5× 300 1.0× 262 1.6× 72 0.5× 43 0.4× 50 544
I. Kindts Belgium 9 305 0.7× 156 0.5× 156 0.9× 233 1.6× 192 1.8× 25 581
Gaia Piperno Italy 15 334 0.8× 182 0.6× 153 0.9× 172 1.2× 21 0.2× 57 648

Countries citing papers authored by Erwin M. Wiegman

Since Specialization
Citations

This map shows the geographic impact of Erwin M. Wiegman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin M. Wiegman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin M. Wiegman more than expected).

Fields of papers citing papers by Erwin M. Wiegman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin M. Wiegman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin M. Wiegman. The network helps show where Erwin M. Wiegman may publish in the future.

Co-authorship network of co-authors of Erwin M. Wiegman

This figure shows the co-authorship network connecting the top 25 collaborators of Erwin M. Wiegman. A scholar is included among the top collaborators of Erwin M. Wiegman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwin M. Wiegman. Erwin M. Wiegman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stelwagen, J., Coby Meijer, Annemiek Walenkamp, et al.. (2021). Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment. Cancers. 13(22). 5675–5675. 6 indexed citations
2.
Belderbos, J., F. Spoelstra, C. Tissing-Tan, et al.. (2019). The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Elderly Stage III Non-Small Cell Lung Cancer Treated with Definitive Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 105(1). S45–S46. 1 indexed citations
3.
Boers, Jorianne, Annette D van Dalsen, Erwin M. Wiegman, et al.. (2019). Intensified Neoadjuvant Chemoradiotherapy for Patients with Potentially Resectable Esophageal Cancer: A Retrospective Cohort Study. Annals of Surgical Oncology. 27(5). 1520–1528. 3 indexed citations
4.
Beck, Naomi, Erwin M. Wiegman, Hans J.M. Smit, et al.. (2018). Lessons learned from the Dutch Institute for Clinical Auditing: the Dutch model for quality assurance in lung cancer treatment. Journal of Thoracic Disease. 10(S29). S3472–S3485. 18 indexed citations
5.
Bollineni, Vikram Rao, Michel Koole, Jan Pruim, et al.. (2014). Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: Possible implications for radiotherapy treatment planning strategies. Radiotherapy and Oncology. 113(2). 198–203. 57 indexed citations
6.
Wiegman, Erwin M., Joachim Widder, Ellen M. Driever, et al.. (2014). Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer. Radiation Oncology. 9(1). 190–190. 8 indexed citations
7.
Wiegman, Erwin M., Martijn de Groot, Hans Paul van der Laan, et al.. (2014). The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients. Radiotherapy and Oncology. 110(2). 284–290. 23 indexed citations
8.
Bisschop, Kees, Jolien J. Tjalma, Geke A.P. Hospers, et al.. (2014). Consequence of Restaging After Neoadjuvant Treatment for Locally Advanced Rectal Cancer. Annals of Surgical Oncology. 22(2). 552–556. 6 indexed citations
9.
Bollineni, Vikram Rao, Jan Pruim, Roel J.H.M. Steenbakkers, et al.. (2013). PET Imaging of Tumor Hypoxia Using 18F-Fluoroazomycin Arabinoside in Stage III–IV Non–Small Cell Lung Cancer Patients. Journal of Nuclear Medicine. 54(8). 1175–1180. 69 indexed citations
10.
Widder, Joachim, Theo J. Klinkenberg, Jan F. Ubbels, et al.. (2013). Pulmonary oligometastases: Metastasectomy or stereotactic ablative radiotherapy?. Radiotherapy and Oncology. 107(3). 409–413. 100 indexed citations
11.
Bollineni, Vikram Rao, Joachim Widder, Jan Pruim, Johannes A. Langendijk, & Erwin M. Wiegman. (2012). Residual 18F-FDG-PET Uptake 12 Weeks After Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer Predicts Local Control. International Journal of Radiation Oncology*Biology*Physics. 83(4). e551–e555. 69 indexed citations
12.
Bollineni, Vikram Rao, Erwin M. Wiegman, Jan Pruim, Harry J.M. Groen, & Johannes A. Langendijk. (2012). Hypoxia imaging using Positron Emission Tomography in non-small cell lung cancer: Implications for radiotherapy. Cancer Treatment Reviews. 38(8). 1027–1032. 32 indexed citations
13.
Wiegman, Erwin M., Jan Pruim, Jan F. Ubbels, et al.. (2011). 18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study. European Journal of Nuclear Medicine and Molecular Imaging. 38(6). 1059–1063. 15 indexed citations
14.
Widder, Joachim, Douwe Postmus, Jan F. Ubbels, Erwin M. Wiegman, & Johannes A. Langendijk. (2011). Survival and Quality of Life After Stereotactic or 3D-Conformal Radiotherapy for Inoperable Early-Stage Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 81(4). e291–e297. 61 indexed citations
15.
Bollineni, Vikram Rao, Erwin M. Wiegman, Jan Pruim, Johannes A. Langendijk, & Joachim Widder. (2011). 9010 ORAL 18F-FDG-PET 12 Weeks After Stereotactic Body Radiotherapy for Stage I Non-Small-Cell Lung Cancer Predicts Outcome. European Journal of Cancer. 47. S595–S595. 1 indexed citations
16.
Grutters, Janneke P.C., Manuela Joore, Erwin M. Wiegman, et al.. (2010). Health-related quality of life in patients surviving non-small cell lung cancer. Thorax. 65(10). 903–907. 80 indexed citations
17.
Wiegman, Erwin M., et al.. (2010). PET/CT and radiotherapy in prostate cancer.. PubMed. 54(5). 543–52. 5 indexed citations
18.
Wiegman, Erwin M., et al.. (2007). TGFβ-1 dependent fast stimulation of ATM and p53 phosphorylation following exposure to ionizing radiation does not involve TGFβ-receptor I signalling. Radiotherapy and Oncology. 83(3). 289–295. 37 indexed citations
19.
Wiegman, Erwin M., et al.. (2004). Post-irradiation dietary vitamin E does not affect the development of radiation-induced lung damage in rats. Radiotherapy and Oncology. 72(1). 67–70. 5 indexed citations
20.
Wiegman, Erwin M., H. Meertens, A. W. T. Konings, Harm H. Kampinga, & Robert P. Coppes. (2003). Loco-regional differences in pulmonary function and density after partial rat lung irradiation. Radiotherapy and Oncology. 69(1). 11–19. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026